Medicine’s Alberto Montero discusses the use of antibody-drug conjugates as cancer treatment method

What to expect from an antibody-drug conjugate for HR+/HER2- metastatic breast cancer

Everyday HealthAlberto Montero, professor at the School of Medicine, discussed the use of antibody-drug conjugates as a treatment method that appears to be more effective than traditional chemotherapy for slowing cancer progression and extending survival.